On November 6, 2023, Wall Street Zen upgraded its rating for Structure Therapeutics (NASDAQ: GPCR) from “sell” to “hold.” This decision reflects a shift in sentiment...
On November 28, 2023, Wall Street Zen upgraded Structure Therapeutics (NASDAQ: GPCR) from a “sell” rating to a “hold” rating. This change comes as a part...